<DOC>
	<DOCNO>NCT00534599</DOCNO>
	<brief_summary>This study carry see extended release quetiapine fumarate ( SeroquelÂ®XL ) add standard selective serotonin reuptake inhibitor ( SSRI ) / serotonin-norepinephrine reuptake inhibitor ( SNRI ) therapy effective safe treatment Generalized Anxiety Disorder patient partial response SSRI/SNRI alone combination benzodiazepine , , compare placebo</brief_summary>
	<brief_title>Generalized Anxiety Disorder Adjunct Study</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision Informed Consent Documented diagnosis Generalized Anxiety Disorder Female patient must pregnant willing use reliable method birth control Be able understand comply study requirement Other psychiatric disorder could confound study result , judge study doctor Moderate severe depression Other clinically relevant disease , judge study doctor Medication taking , judge study doctor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Generalized anxiety disorder</keyword>
	<keyword>anxiety</keyword>
	<keyword>adjunct treatment anxiety</keyword>
	<keyword>anxiety disorder</keyword>
	<keyword>partial non-responder anxiety</keyword>
</DOC>